Acquired hemophilia in chronic lymphocytic leukemia [4]

Leukemia and Lymphoma

Volumn 48, Issue 5, 2007, Pages 1026-1028

  Mahipal, Amit ^a,b   Bilgrami, S ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR; CYCLOPHOSPHAMIDE; FLUDARABINE; HEMOGLOBIN; PREDNISONE; RITUXIMAB;

AGED; ANAMNESIS; BLOOD CLOTTING TEST; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HEMOPHILIA; HUMAN; LABORATORY TEST; LETTER; LEUKOCYTE COUNT; LYMPHADENOPATHY; LYMPHOCYTE COUNT; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PARTIAL THROMBOPLASTIN TIME; PHYSICAL EXAMINATION; PNEUMONIA; PRIORITY JOURNAL; PROTHROMBIN TIME; SEPSIS; SPLENOMEGALY; THROMBOCYTE COUNT; TREATMENT DURATION;

AGED; AUTOANTIBODIES; CYCLOPHOSPHAMIDE; FACTOR VIII; FEMALE; HEMOPHILIA A; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; TIME FACTORS; TREATMENT OUTCOME; VIDARABINE;

EID: 34547474912     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701203962     Document Type: Letter

References (19)

1. Green, D. and Lechner, K. (1981) A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost, 45, pp. 200-203.
2. Bossi, P., Cabane, J., Ninet, J., Dhote, R., Hanslik, T. and Chosidow, O. (1998) Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med, 105, pp. 400-408.
3. Kesley, P. R. and Leyland, M. J. (1982) Acquired inhibitor to human factor VIII associated with paraproteinemia and subsequent development of chronic lymphocytic leukemia. Br Med J, 285, pp. 174-176.
4. Mateo, J., Martino, R., Borrell, M., Gari, M., Casas, F. and Fontcuberta, J. (1993) Acquired factor VIII inhibitor preceding chronic lymphocytic leukemia. Ann Hematol, 67, pp. 309-311.
5. Schwartz, R. S., Gabriel, D. A., Aledort, L. M., Green, D. and Kessler, C. M. (1995) A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood, 86, pp. 797-804.
6. Ceballos, P., Yeche, S., Reynaud, D., Mouliade, C. and Dubois, A. (1996) Inhibiteur acquis du factor VIII et leucemie lymphoide chronique:a propos d'un cas. Rev Med Interne, 17, pp. 150-153.
7. DiBona, E., Schiavoni, M., Castaman, G., Ciavarella, N. and Rodeghiero, F. (1997) Acquired hemophilia: Experience of two Italian centers with 17 new cases. Haemophilia, 3, pp. 183-188.
8. Ghirarduzzi, A., Silingardi, M., D'Inca, M. and Tincani, E. (1999) Sindrome da anticorpi antifosfolipida in corso di leukemia linfatica cronica. Associazione con autoanticorpi anti-fattore VIII. Ann Ital Med Int, 14, pp. 46-50.
9. Blanche, P., Bouscary, D., Gombert, B., Stieltjes, N., Dreyfus, F. and Sicard, D. (1999) Successful treatment of acquired factor VIII inhibitor with fludrarabine and cyclophosphamide in chronic lymphoid leukemia. Leukemia 13, p. 1294.
10. Sallah, S., Nguyen, N. P., Abdallah, J. M. and Hanrahan, L. R. (2000) Acquired hemophilia in patients with hematologic malignancies. Arch Pathol Lab Med, 124, pp. 730-734.
11. Hall, R. L. and Leahy, M. F. (2001) Acquired factor VIII autoantobody: four cases demonstrating the heterogenous nature of this condition and problems involved in diagnosis and treatment. Eur J Haematol, 66, pp. 206-209.
12. Diehl, L. F. and Ketchum, L. H. (1998) Autoimmune disease and chronic lymphocytic leukemia: Autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol, 25, pp. 80-97.
13. Kyasa, M. J., Parrish, R. S., Schichman, S. A. and Zent, C. S. (2003) Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol, 74, pp. 1-8.
14. Goodrick, M. J., Prentice, A. G., Copplestone, J. A., Pamphilon, D. H. and Boon, R. J. (1992) Acquired factor XI inhibitor in chronic lymphocytic leukaemia. J Clin Pathol, 45, pp. 352-353.
15. Zeitler, H., Ulrich-Merzenich, G., Hess, L., Konsek, E., Unkrig, C. and Walger, P. (2005) Treatment of acquired hemophilia by the Bonn-Malmo Protocol: Documentation of an in vivo immunomodulating concept. Blood, 105, pp. 2287-2293.
16. Longo, G., Luppi, M., Ferrara, L., Torelli, U., Barbieri, U. and Torelli, G. (1996) Acquired factor VIII inhibitor at the onset of prolymphocytic leukemia. Leukemia, 10, pp. 1557-1558.
17. Hay, C. R., Brown, S., Collins, P. W., Keeling, D. M. and Liesner, R. (2006) The diagnosis and management of factor VIII and IX inhibitors: A guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol, 133, pp. 591-605.
18. D'Arena, G., Laurenti, L., Capalbo, S., D'Arco, A. M., De Filippi, R. and Marcacci, G. (2006) Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. Am J Hematol, 81, pp. 598-602.
19. Wiestner, A., Cho, H. J., Asch, A. S., Michelis, M. A., Zeller, J. A. and Peerschke, E. I. (2002) Rituximab in the treatment of acquired factor VIII inhibitors. Blood, 101, pp. 3426-3428.